Current status of development of methylation biomarkers for in vitro diagnostic IVD applications

A significant volume of research clearly shows that disease-related methylation changes can be used as biomarkers at all stages of clinical disease management, including risk assessment and predisposition screening through early diagnostics to personalization of patient care and monitoring of the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Taryma-Leśniak, Olga, Sokolowska, Katarzyna Ewa, Wojdacz, Tomasz Kazimierz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336678/
https://www.ncbi.nlm.nih.gov/pubmed/32631437
http://dx.doi.org/10.1186/s13148-020-00886-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336678/
https://www.ncbi.nlm.nih.gov/pubmed/32631437
http://dx.doi.org/10.1186/s13148-020-00886-6

Ejemplares similares